PTEN: Possible Predictive Marker Related to Sentinel Lymph Node Micro-Metastasis in Breast Cancer Patients

ZHU Li,Louis WC CHOW,LI Ya-fen,Wings TY LOO,ZHU Zheng-gang,LI Hong-wei

DOI: https://doi.org/10.3969/j.issn.1007-9610.2005.04.021

2005-01-01

Abstract:Objective To assess the ability of expression of PTEN as a predictor for micro-metastasis in breast cancer patients. Methods As destination sites for micro-metastasis, peripheral blood (BD), bone marrow (BM) and sentinel lymph node (SLN) from 53 breast cancer patients were examined. Protein and gene expressions of PTEN at the primary site were determined by immunohistochemistry (IHC) and real-time reverse transcript polymerase chain reaction (RT-PCR) respetivdy. BD and BM samples were processed using immunocytochemistry (ICC). SLNs were examined by hematoxylin and eosin (HE) staining and IHC. Results The percentage of micro-metastasis was 24.5% for BD, 56.6% for BM, 26.4% in SLN by HE and 41.5% in SLN by IHC. Loss of PTEN expression was significantly associated with SLN micro-metastasis as shown both by HE and IHC (P0.001). On the contrary, there was no significant correlation between PTEN expression and micro-metastasis in the BD and the BM. Meanwhile, there was no significant correlation between PTEN gene amplification and the presence of micro-metastasis in different homing sites. Conclusions Loss of PTEN expression in the primary tumor is significantly correlated with SLN micro-metastasis but not with BD and BM micro-metastasis from patients with breast cancer. Loss of PTEN might predict the risk for SLN micro-metastasis in breast cancer patients.